Table 2 Per-patient Lifetime Costs under the Main Examined Medication Scenarios, by Resource Type and Healthcare Setting
From: Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
Aspirin | Dabigatran 150 mg | Rivaroxaban 20 mg | Δ Dabigatran vs. Aspirin | Δ Rivaroxaban vs. Aspirin | ||
|---|---|---|---|---|---|---|
United States | Ischaemic Strokes | $8,477.30 | $5,934.11 | $5,934.11 | − $2,543.19 | − $2,543.19 |
Bleeding Events | $31,867.78 | $37,443.42 | $41,953.51 | $5,575.64 | $10,085.73 | |
Prescriptions | $259.38 | $23,994.99 | $24,976.10 | $23,735.61 | $24,716.72 | |
TOTAL | $40,604.46 | $67,372.52 | $72,863.72 | $26,768.06 | $32,259.26 | |
United Kingdom | Ischaemic Strokes | £4,953.06 | £3,467.14 | £3,467.14 | − £1,485.92 | − £1,485.92 |
Bleeding Events | £2,619.19 | £2,565.92 | £3,181.65 | − £53.27 | £562.46 | |
Prescriptions | £123.19 | £7,615.42 | £8,064.49 | £7,492.23 | £7,941.30 | |
TOTAL | £7,695.44 | £13,648.49 | £14,713.29 | £5,953.04 | £7,017.84 | |
Netherlands | Ischaemic Strokes | €1,141.41 | €798.99 | €798.99 | − €342.42 | − €342.42 |
Bleeding Events | €3,342.24 | €3,934.81 | €4,404.05 | €592.57 | €1,061.81 | |
Prescriptions | €3,173.39 | €9,605.93 | €9,821.69 | €6,432.54 | €6,648.30 | |
TOTAL | €7,657.04 | €14,339.73 | €15,024.73 | €6,682.69 | €7,367.69 | |
Spain | Ischaemic Strokes | €2,377.23 | €1,664.06 | €1,664.06 | − €713.17 | − €713.17 |
Bleeding Events | €4,640.58 | €5,299.34 | €6,029.50 | €658.76 | €1,388.92 | |
Prescriptions | €986.27 | €5,974.15 | €9,689.00 | €4,987.88 | €8,702.73 | |
TOTAL | €8,004.08 | €12,937.55 | €17,382.57 | €4,933.47 | €9,378.48 | |
Australia | Ischaemic Strokes | AUD$7,141.27 | AUD$4,998.89 | AUD$4,998.89 | − AUD$2,142.38 | − AUD$2,142.38 |
Bleeding Events | AUD$6,328.85 | AUD$6,831.18 | AUD$8,016.72 | AUD$502.33 | AUD$1,687.87 | |
Prescriptions | AUD$554.31 | AUD$7,547.08 | AUD$7,548.11 | AUD$6,992.77 | AUD$6,993.80 | |
TOTAL | AUD$14,024.43 | AUD$19,377.15 | AUD$20,563.72 | AUD$5,352.72 | AUD$6,539.29 | |